Home LiteratureArticle Details
PMID: 15470081 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Hepatic expression of the UGT1A9 gene is governed by hepatocyte nuclear factor 4alpha.

Molecular pharmacology ·Vol. 67 ·No. 1 ·2005-01-00 ·Pages 241-9

Barbier O, Girard H, Inoue Y, Duez H, Villeneuve L, Kamiya A, Fruchart JC, Guillemette C, Gonzalez FJ, Staels B

Abstract

UDP-glucuronosyltransferase (UGT) enzymes catalyze the glucuronidation reaction, which is a major pathway in the catabolism and elimination of numerous endo- and xenobiotics. Among the UGT enzyme family members, the UGT1A7, UGT1A8, UGT1A9, and UGT1A10 isoforms are issued from a single gene through differential splicing. However, these enzymes display distinct tissue-specific expression patterns. Indeed, UGT1A7, UGT1A8, and UGT1A10 are exclusively expressed in extrahepatic tissues, whereas UGT1A9 transcripts are found at high concentrations in liver. In the present study, we report that the liver-enriched hepatocyte nuclear factor 4 (HNF4)-alpha controls the hepatic expression of the UGT1A9 enzyme. Liver-specific disruption of the HNF4alpha gene in mice drastically decreases liver UGT1A9 mRNA levels. Furthermore, an HNF4alpha response element (HNF4alpha RE) was identified in the promoter of human UGT1A9 at position -372 to -360 base pairs by transient transfection, electrophoretic mobility shift assays, and chromatin immunoprecipitation experiments. It is interesting that this response element is absent in the proximal UGT1A7, UGT1A8, and UGT1A10 gene promoters. In conclusion, the present study identifies HNF4alpha as a major factor for the control of UGT1A9 hepatic expression and suggests that the absence of UGT1A7, UGT1A8, and UGT1A10 expression in the liver is caused by, at least in part, a few base pair changes in their promoter sequences in the region corresponding to the HNF4alpha RE of the UGT1A9 gene.

MeSH Terms
Carcinoma, Hepatocellular Cell Line, Tumor Cloning, Molecular DNA-Binding Proteins/physiology Gene Expression Regulation, Enzymologic/physiology Glucuronosyltransferase/genetics Hepatocyte Nuclear Factor 4 Humans Liver/enzymology Mutagenesis, Site-Directed Phosphoproteins/physiology Plasmids Promoter Regions, Genetic Recombinant Proteins/metabolism Restriction Mapping Reverse Transcriptase Polymerase Chain Reaction Transcription Factors/physiology UDP-Glucuronosyltransferase 1A9
Chemicals
DNA-Binding Proteins HNF4A protein, human Hepatocyte Nuclear Factor 4 Phosphoproteins Recombinant Proteins Transcription Factors UGT1A9 protein, human Ugt1a9 protein, mouse Glucuronosyltransferase UDP-Glucuronosyltransferase 1A9
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Barbier Olivier
Unité INSERM 545, Institut Pasteur de Lille, 1 rue du Pr Calmette, BP 245, 59019 Lille, France.
Girard Hugo
Inoue Yusuke
Duez Hélène
Villeneuve Lyne
Kamiya Akihide
Fruchart Jean-Charles
Guillemette Chantal
Gonzalez Frank J
Staels Bart
Article Info
Journal
Molecular pharmacology
Abbr.
Mol Pharmacol
ISSN
0026-895X
Published
2005-01-00
Epub
2004-00-06
Pages
241-9
Language
English
Region
United States
NLM ID
0035623
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com